Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Novartis India Ltd. shows significant weaknesses in growth and profitability metrics compared to its peers, positioning it as a sector laggard. The company has no revenue growth, zero profitability ratios, and lacks overall financial performance, making it less attractive in the current trading environment.
Highest revenue growth (YoY) at 1.53% and strong profitability metrics (ROE of 9.477%).
Strong ROE at 17.1182% and low PE at 13.20, making it a strong value pick.
High ROA and ROE but also a high PE ratio indicating potential overvaluation.